Jennifer Green, senior global technical business development manager at Lubrizol explores importance of device design, as diabetes management is rapidly advancing, and the choice of materials is what helps distinguish good design.
With so much investor interest surrounding the potential of allogeneic CAR T cell therapies, the stakes are high for innovators to ensure that their inventions are robustly protected from the start.
What’s the best way to introduce AI to enhance automation of high-volume pharmacovigilance activities, such as adverse event case intake and processing?
Rachel Houghton, managing director at Business Moves Group (BMG), explores how pharmaceutical manufacturers can navigate complex regulatory landscapes and safeguard sensitive equipment to ensure seamless international workplace transitions.
Kayla Pham, vice president of quality at Best Formulations/Sirio Pharma shares why more and more, nutrition and nutraceuticals brand owners are placing pharma-grade quality control atop their manufacturing partnership wish lists.
Tom Moody, Jonathan Loughrey, Martin McCabe, Scott Wharry and Stephen Hughes, Almac Group, explores vertical integration of supply chains and technology integration in Active Pharmaceutical Ingredient (API) manufacture.
